• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAH091502E
Device Problems Separation Failure (2547); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/27/2021
Event Type  Injury  
Event Description
It was reported to gore that the patient underwent endovascular treatment for a popliteal artery aneurysm with a gore® viabahn® endoprosthesis with propaten bioactive surface.It was stated that the proximal part of the device did not fully deploy.The deployment was stuck and after several attempts of pulling the deployment line it broke.It was reported that the last 5 mm of the endoprosthesis did not deploy and was stuck on the catheter.About 6 hours later the patients popliteal artery was blocked and a surgical reintervention had to be done.It was stated that the deployment line and catheter fragments as well as the top part of the prosthesis were removed.The patient tolerated the procedure.
 
Manufacturer Narrative
Evaluation codes investigation findings 213 refers to the product history review: a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.An engineering investigation of an accessory and of a part of the prosthesis as well as an imaging evaluation have to be performed.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
Imaging evaluation the images received cannot be used to perform a full imaging evaluation.The extent and accuracy of the observations and findings may be limited due to the completeness, format and/or quality of the available images provided for review.Gore cannot guarantee the images provided are accurate or lack alteration.Therefore, gore cannot guarantee all key findings have been captured or that the findings are accurate.Summary: three jpeg radiographic images received for evaluation.No names, dates, or demographics included on the images.First jpeg image appears to show: the hub end of the implanted device is not fully deployed and appears to remain on the deployment catheter.Radiopaque marker at the hub end appears to be in place and no deployment line can be visualized.The 2nd and 3rd jpeg images appears to show: the hub end of the implanted device is still not fully deployed.The deployment catheter is pulled back, by location of the radiopaque marker.There appears to be a broken deployment line present.Engineering evaluation evaluation of the returned device items is consistent with the reported complaint but is unable to confirm the partial deployment.A broken deployment line, cut delivery catheter, and cut endoprosthesis were observed.Returned device the delivery catheter, distal tip and partial distal shaft (separated), deployment line, and hub were returned.Part of the endoprosthesis was returned deployment knob was not attached to the hub as-returned deployment line deployment line is fully outside the delivery catheter the deployment line is broken 207.8cm of deployment line is attached to the hub zipper: 11mm of the zipper constrains a section of the endoprosthesis distal shaft cut 14.5cm from the transition 1.6cm of distal shaft is attached to distal tip dual lumen has a minor kink 92cm from the hub endoprosthesis.The endoprosthesis appears cut 1.1 cm length of endoprosthesis was returned constrained by the zipper.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12868234
MDR Text Key281197116
Report Number2017233-2021-02568
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeNL
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/07/2022
Device Catalogue NumberPAH091502E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/05/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
Patient SexMale
-
-